Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-22T16:32:16.741Z Has data issue: false hasContentIssue false
  • English
  • Français

Phage typing of Vero cytotoxin-producing Escherichia coli O 157 isolated in the United Kingdom: 1989–91

Published online by Cambridge University Press:  15 May 2009

J. A. Frost ,
T. Cheasty ,
A. Thomas  and
B. Rowe
J. A. Frost
Affiliation:
Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61, Colindale Avenue, London NW6 5HT
T. Cheasty
Affiliation:
Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61, Colindale Avenue, London NW6 5HT
A. Thomas
Affiliation:
Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61, Colindale Avenue, London NW6 5HT
B. Rowe
Affiliation:
Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61, Colindale Avenue, London NW6 5HT
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Between 1989 and 1991 a total of 1092 Vero cytotoxin-producing Escherichia coli O 157 isolated in the United Kingdom were phage typed in the Laboratory of Enteric Pathogens (LEP). Twenty-three phage types was identified, the most frequent being types 2 (36·1%), 49 (29·6%), 1 (10·3%) and 4 (8·9%). Although isolations of O 157 VTEC have increased each year from 1 in 1982 to 532 in 1991, the predominant phage types have remained unchanged although the proportion of strains belonging to types 2 and 49 has increased. O 157 VTEC from 17 outbreaks were phage typed during this period with phage type 49 predominating (7 of 17 outbreaks).

Type
Research Article
Information
Epidemiology & Infection , Volume 110 , Issue 3 , June 1993 , pp. 469 - 475
Copyright
Copyright © Cambridge University Press 1993

References

REFERENCES

1.Konowalchuk, J, Spiers, JI, Stavric, S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18: 775–9.CrossRefGoogle ScholarPubMed
2.Griffin, PM, Ostroff, SM. Tauxe, RV. et al. Illnesses associated with Escherichia coli O 157. H7. Ann Int Med 1988; 109: 705–12.CrossRefGoogle Scholar
3.Smith, HR. Rowe, B. Gross, RJ, Fry, NK, Scotland, SM. Haemorrhagic colitis and Vero-cytotoxin producing Escherichia coli in England and Wales. Lancet 1987; i: 1062–5.CrossRefGoogle Scholar
4.Karmali, MA. Steele, BT. Petric, M, Lim, C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin producing Escherichia coli in stools. Lancet 1983; i: 619–20.CrossRefGoogle Scholar
5.Scotland, SM, Rowe, B. Smith, HR. Willshaw, GA, Gross, RJ. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol 1988; 25: 237–43.CrossRefGoogle ScholarPubMed
6.Karmali, MA. Infection by Verocytotoxin-producing Escherichia coli. Clin Microbiol Revs 1989; 2: 15–38.CrossRefGoogle ScholarPubMed
7.Taylor, CM, White, RHR, Winterborn, MH, Rowe, B. Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. BMJ 1986; 292: 1513–6.CrossRefGoogle ScholarPubMed
8.Thomas, A, Chart, H, Cheasty, T, Smith, HR, Frost, JA. Rowe, B. Vero cytotoxin-producing Escherichia coli. particularly serogroup O 157. associated with human infections in the United Kingdom: 1989–91. Epidemiol Infect 1993; 110: 591–600.CrossRefGoogle ScholarPubMed
9.Cheasty, T, Thomas, A. Chart, H, Smith, HR, Rowe, B. Vero cytotoxinproducing Escherichia coli O 157 in the United Kingdom. 1992. CDR Review; 2: R140–1.Google ScholarPubMed
10.Hall, SM. Haemolytic ureamic syndrome, 1989. British Paediatric Surveillance Unit. Annual Report. 1989.Google Scholar
11.Willshaw, GA. Smith, HR, Scotland, SM, Field, AM, Rowe, B, Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol 1987: 133: 1309–17.Google ScholarPubMed
12.Ahmed, R, Bopp, C, Borczyk, A, Kasatiya, S. Phage typing scheme for Escherichia coli O 157: H7. J Infect Dis 1987: 155: 806–9.CrossRefGoogle Scholar
13.Khakhria, R, Duck, D, Lior, H. Extended phage-type scheme for Escherichia coli O 157: H7. Epidemiol Infect 1990; 155: 511–20.CrossRefGoogle Scholar
14.Frost, JA, Smith, HR, Willshaw, GA, Scotland, SM, Gross, RJ, Rowe, B. Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O 157 isolated in the United Kingdom. Epidemiol Infect 1989: 103: 73–81.CrossRefGoogle Scholar
15.Gross, RJ, Rowe, B. Serotyping of Escherichia coli. In: The virulence of Escherichia coli. Reviews and Methods. Sussman, M. ed. London: Academic Press, 1985: 345–63.Google Scholar
16.Marsh, J, MacLeod, AF, Hansen, MF, Emmanuel, FXS, Frost, JA, Thomas, A. A restaurant-associated outbreak of E. coli O 157 infection. J Publ Health Med 1992; 14: 78–83.Google Scholar
17.Anonymous. Verotoxin producing Escherichia coli O 157: phage type 49. PHLS Comm Dis Rep 1991; 1. No. 47: 1.Google Scholar
18.Anonymous. Haemorrhagic colitis: Escherichia coli O 157. PHLS Comm Dis Rep 1991; 1. No. 6: 1.Google Scholar
19.Scotland, SM, Rowe, B, Smith, HR. Willshaw, GA. Gross, RJ. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol 1988; 25: 237–53.CrossRefGoogle ScholarPubMed
20.Kleanthous, H, Smith, HR. Scotland, , et al. Haemolytic uraemic syndromes in the British lsles. 1985–1988: association with Verocytotoxin producing Escherichia coli Part 2: Microbiological aspects. Arch Dis Child 1990; 65: 722–7.CrossRefGoogle Scholar
21.Griffin, PM, Tauxe, RV. The epidemiology of infections caused by Escherichia coli O 157: H7. other enterohemorrhagic E. coli. and the associated Hemolytic Uraemic Syndrome. Epidemiol Rev 1991; 13: 60–98.CrossRefGoogle Scholar